Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,816 across all filing types
Latest filing 2024-05-27 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions in Connection with Share Buy-back Program
Transaction in Own Shares Classification · 1% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, total value, and the impact on treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS). Although it mentions attachments, the text itself contains the core data of the report, distinguishing it from a mere publication notice.
2024-05-27 Danish
6-K
Foreign Filer Report
2024-05-21 English
6-K
Foreign Filer Report
2024-05-21 English
M&A Activity 2024
M&A Activity Classification · 1% confidence The document is titled "Company Announcement" and details the completion of a major corporate action: the acquisition of ProfoundBio by Genmab for USD 1.8 billion. It discusses strategic implications, pipeline integration (Rina-S), and provides updated financial guidance expectations related to the transaction. This type of announcement, focusing on a significant corporate event like an acquisition, does not fit neatly into standard periodic reports (10-K, IR, ER) or specific shareholder actions (DIV, DVA). Since it is a material corporate event announcement that doesn't map to a more specific category like M&A Activity (TAR, which usually covers the proposal/bid phase), the most appropriate general category for a significant, non-standard corporate update that is not a standard financial filing is Regulatory Filings (RNS), which serves as a broad category for material company announcements not covered elsewhere, or potentially Capital/Financing Update (CAP) due to the large cash transaction, but RNS is broader for general material news. Given the context of a major corporate action announcement, RNS is the best fit as a catch-all for significant, non-periodic news.
2024-05-21 English
Genmab Completes Acquisition of ProfoundBio
Capital/Financing Update Classification · 1% confidence The document is a corporate announcement regarding the completion of an acquisition (Genmab acquiring ProfoundBio). While it contains details about the transaction, it is structured as a formal company announcement (Company Announcement no. 38) and includes a link to an attachment. Under the 'Menu vs Meal' rule, this is a regulatory announcement regarding a corporate event (M&A activity). Since the category 'TAR' (M&A Activity) is specifically defined for announcements and documents related to merger proposals or takeover bids, this is the most accurate classification.
2024-05-21 Danish
Transaction in Own Shares 2024
Transaction in Own Shares Classification · 1% confidence The document is titled "Transactions in Connection with Share Buy-back Program" and details the number of shares repurchased by Genmab A/S between May 13, 2024, and May 17, 2024, under an existing buy-back program. This activity directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a detailed announcement, not just a notice that a report is attached, so RPA/RNS is not the primary classification.
2024-05-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.